Friday, September 19, 2025
News Health
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health
No Result
View All Result
HealthNews
No Result
View All Result
Home Health News

NICE Urges Ongoing Support After Obesity Treatment

August 5, 2025
in Health News
Share on FacebookShare on Twitter


The National Institute for Health and Care Excellence (NICE) has released updated guidance recommending that healthcare providers offer structured, ongoing support to patients after they complete obesity treatment or stop taking weight-loss medications. 

This includes regular follow-up care, tailored action plans, and social support to help patients maintain their weight loss and avoid regaining weight.

New Drugs Raise Need for Long-Term Support

The new quality standard comes as weight-loss medications such as semaglutide (Wegovy) and tirzepatide (Mounjaro) are being introduced on the NHS. An estimated 240,000 people are set to be offered tirzepatide over the next 3 years. 

The update addresses a critical gap in current care, noting that many people regain weight after treatment if they lack adequate support, with consequences for both physical and mental health. 

In England, 29% of adults are living with obesity and 64% of adults are classified as overweight or obese. Obesity-related illnesses are estimated to cost the NHS £11.4 billion a year and have a wider economic impact of £74.3 billion.

Ensuring Continuity of Care

The guidance stresses that weight management is a long-term process, not a one-time fix. It recommends that healthcare providers ensure continuity of care by monitoring patients for at least 12 months and offering tailored support to help maintain weight loss. This may include NHS Better Health resources and strategies for habit change, as well as practical adjustments at home or at work.

The quality standard advocates for a shift from short-term interventions to strategies that foster lasting behavioural changes. It highlights the importance of self-monitoring and connecting patients with broader support networks, such as online communities, family-led initiatives, and local programmes.

Guidance Implementation

Professor Jonathan Benger, deputy chief executive of NICE, noted that weight management “doesn’t end when medication stops or when someone completes a behavioural programme,” adding that “people need structured support to maintain the positive changes they’ve made.”

The new guidance replaces three previous standards and reflects the most up-to-date strategies for tackling obesity through the healthcare system. 

Healthcare services are advised to begin implementing the standard immediately, with resource impact guidance available to assist in local adaptation.



Source link : https://www.medscape.com/viewarticle/nice-urges-ongoing-support-after-obesity-treatment-2025a1000ksg?src=rss

Author :

Publish date : 2025-08-05 15:34:00

Copyright for syndicated content belongs to the linked Source.

Previous Post

The World Nearly Beat Polio: Fake Records and an Imperfect Vaccine Aided Its Return

Next Post

Why constipation isn’t just painful, but can lead to serious disease

Related Posts

Health News

Naltrexone-Bupropion May Curb Postbariatric Weight Regain

September 19, 2025
Health News

Gene Therapy Shows Signal for Improving Retinal Function

September 19, 2025
Health News

Ruxolitinib Cream Approved for Children Aged 2-11 With AD

September 19, 2025
Health News

Doctor sexual misconduct hearings too lenient, says UK review

September 19, 2025
Health News

CDC Panel Recommends Against MMRV Vaccine in Young Kids

September 18, 2025
Health News

JAK Inhibitor Benefits in Type 1 Diabetes Lost After Discontinuation

September 18, 2025
Load More

Naltrexone-Bupropion May Curb Postbariatric Weight Regain

September 19, 2025

Gene Therapy Shows Signal for Improving Retinal Function

September 19, 2025

Ruxolitinib Cream Approved for Children Aged 2-11 With AD

September 19, 2025

Doctor sexual misconduct hearings too lenient, says UK review

September 19, 2025

CDC Panel Recommends Against MMRV Vaccine in Young Kids

September 18, 2025

JAK Inhibitor Benefits in Type 1 Diabetes Lost After Discontinuation

September 18, 2025

Psoriasis Patients Could Benefit From GLP-1 Therapy

September 18, 2025

Trump Administration Moves to Close ‘Failing’ Organ Donation Agency

September 18, 2025
Load More

Categories

Archives

September 2025
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
2930 
« Aug    

© 2022 NewsHealth.

No Result
View All Result
  • Health News
  • Hair Products
  • Nutrition
    • Weight Loss
  • Sexual Health
  • Skin Care
  • Women’s Health
    • Men’s Health

© 2022 NewsHealth.

Go to mobile version